RxDoctor Payments DataLook up a doctor →

Melissa Carver

Nurse Practitioner · Tampa, FLNPI 1699755819

Payments from drug & device makers

$129,024in general payments, 2019–2025

Across 691 payments — averaging $186.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$82K
  • Gilead$23K
  • Pfizer$9K
  • Novartis$2K
  • Seagen Inc.$2K
  • Astellas Pharma US Inc$990
  • plus $9K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech USA, Inc.112$81,651
Gilead(2 entities)97$23,453
Pfizer50$8,953
Novartis70$2,427
Seagen Inc.14$2,379
Astellas Pharma US Inc12$990
E.r. Squibb & Sons, L.L.C.47$900
AstraZeneca20$897
Johnson & Johnson21$594
AbbVie21$577
Epizyme, Inc.2$517
Bristol Myers Squibb18$422
Daiichi Sankyo Inc.11$380
Eisai Inc.16$370
GSK13$354
Merck15$317
Sanofi15$311
Exelixis Inc.8$310
Lilly USA, LLC12$307
Incyte Corporation9$238
Rigel Pharmaceuticals, Inc.3$209
Pharmacyclics LLC, An Abbvie Company7$167
Tersera Therapeutics LLC5$145
Blueprint Medicines Corporation2$145
Puma Biotechnology, Inc.8$143
Sanofi US Services Inc.1$132
Array Biopharma Inc7$127
Amgen6$123
Beigene USA, Inc.5$122
Bayer7$118
Takeda Pharmaceuticals U.S.A., Inc.5$116
Sobi, Inc3$91
AVEO Pharmaceuticals, Inc.5$87
Pharmaessentia USA Corporation3$67
Mirati Therapeutics, Inc.3$64
CSL Behring3$58
Regeneron Healthcare Solutions, Inc.2$56
Beone Medicines USA, Inc.2$54
Geron Corporation2$52
Karyopharm Therapeutics Inc.3$50
Genentech, Inc.1$48
CTI Biopharma Corp.2$46
EMD Serono, Inc.2$42
GE HealthCare2$36
Agios Pharmaceuticals, Inc.2$34
Jazz Pharmaceuticals Inc.1$32
Taiho Oncology, Inc.2$29
Boehringer Ingelheim1$27
Kyowa Kirin, Inc.1$26
Telix Pharmaceuticals1$25
Corcept Therapeutics1$22
Genmab U.S., Inc.1$22
Recordati_rare_diseases_inc.1$22
Heron Therapeutics, Inc.1$21
Apellis Pharmaceuticals, Inc.1$21
Deciphera Pharmaceuticals Inc.1$18
G1 Therapeutics, Inc.1$17
Sumitomo Pharma America, Inc.1$16
Ipsen Biopharmaceuticals, Inc1$16
Morphosys, US Inc.1$16

How this compares

$129,024 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida →

Medicare billing

Part B allowed, 2024
$4,406
Medicare patients
35
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →